Agenda and minutes
Venue: Committee Room 3 - Senedd. View directions
Contact: Fay Bowen
Media
Senedd.TV: View the webcast
Expected timing | No. | Item |
---|---|---|
Transcript View
the meeting transcript
(PDF 594KB) View as HTML
(393KB) |
||
(14.00) |
Introductions, apologies, substitutions and declarations of interest Minutes: 1.1
The
Chair welcomed the Members to the Committee. 1.2
There
were no apologies from Members. Apologies were received from the Auditor
General for Wales. 1.3
Lee
Waters AM declared an interest in that his wife is employed by Cwm Taf
University Health Board (Item 4). |
|
(14.00 - 14.10) |
Paper(s) to note Supporting documents: Minutes: 2.1
The papers were noted. 2.2
It was agreed that the Chair will write to the Permanent Secretary regarding the
challenges digitalisation will bring to the Welsh Government and advise her
that the Committee wish to discuss this issue with her further when she next
attends Committee. |
|
Introductory Session: Additional information from the Permanent Secretary, Welsh Government on Digitalisation (1 June 2017) Supporting documents: |
||
(14.10 - 15.15) |
Medicines Management: Evidence Session 2 Research
Briefing Judy
Henley – Director of Contractor Services, Community Pharmacy Wales Mark
Griffiths - Chair of Community Pharmacy Wales Mair
Davies - Director, Royal Pharmaceutical Society Wales Cheryl
Way – RPS Board Member (Principal Pharmacist, Cardiff and Vale University Health
Board and National Pharmacy and Medicines Management Lead, NHS Wales
Informatics Service) Supporting documents:
Minutes: 3.1
The Committee took evidence from Judy Henley, Director of Contractor Services,
Community Pharmacy Wales; Mark Griffiths, Chair of Community Pharmacy Wales; Elen
Jones, Practice and Policy lead for Royal Pharmaceutical
Society Wales and Cheryl Way, RPS Board Member (Principal Pharmacist, Cardiff
and Vale University Health Board and National Pharmacy and Medicines Management
Lead, NHS Wales Informatics Service) as part of their inquiry into medicines
management. 3.2 The Committee noted that Elen Jones had attended in place of Mair Davies, Director of RPS Wales due to sickness. |
|
(15.30 - 16.45) |
Medicines Management: Evidence Session 3 PAC(5)-17-17
Paper 1 – Paper from Cwm Taf University Health Board PAC(5)-17-17
Paper 2 – Paper from Powys Teaching Health Board PAC(5)-17-17
Paper 3 – Paper from Abertawe Bro Morgannwg University Health Board Allison
Williams – Chief Executive, Cwm Taf University Health Board Suzanne
Scott-Thomas, Chief Pharmacist, Cwm Taf University Health Board Professor
Rory Farrelly – Acting Chief Operating Officer/Deputy Chief Executive &
Director of Nursing and Patient Evidence, Abertawe Bro Morgannwg University
Health Board Judith
Vincent – Clinical Director for Pharmacy and Medicines Management, Abertawe Bro
Morgannwg University Health Board Carol
Shillabeer – Chief Executive, Powys Teaching Health Board Karen
Gully – Medical Director, Powys Teaching Health Board Supporting documents:
Minutes: 4.1
The Committee took evidence from Allison Williams, Chief Executive, Cwm Taf
University Health Board; Suzanne Scott-Thomas, Chief Pharmacist, Cwm Taf
University Health Board; Professor Rory Farrelly, Acting Chief Operating
Officer/Deputy Chief Executive & Director of Nursing and Patient Evidence,
Abertawe Bro Morgannwg University Health Board; Judith Vincent, Clinical
Director for Pharmacy and Medicines Management, Abertawe Bro Morgannwg
University Health Board; Carol Shillabeer, Chief Executive, Powys Teaching
Health Board and Karen Gully, Medical Director, Powys Teaching Health Board as
part of their inquiry into medicines management. 4.2
Judith Vincent agreed to provide additional information on the work Professor
Routledge is facilitating with experts on medicines related admissions regarding
patient safety. |
|
(16.45) |
Motion under Standing Order 17.42 to resolve to exclude the public from the meeting for the following business: Item
6 Minutes: 5.1
The motion was agreed. |
|
(16.45 - 17.00) |
Medicines Management: Consideration of evidence received Minutes: 6.1
Members considered the evidence received. |